Community Pharmacy‐Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program
Community pharmacy-based iOAT represents a novel strategy to expand access to evidence-based opioid use disorder treatment among individuals who inject opioids and have not responded to or do not prefer oral OAT.
Authors
- Christy Sutherland (ORCID: https://orcid.org/0000-0002-2069-4172)
- Cameron Grant
- M. Eugenia Socías (ORCID: https://orcid.org/0000-0003-2556-7049)
- Tamara Mihic (ORCID: https://orcid.org/0000-0002-3487-9186)
- Nadia Fairbairn (ORCID: https://orcid.org/0000-0002-4195-3284)
- Karen McCrae
- Cheyenne Johnson (ORCID: https://orcid.org/0000-0003-2462-0813)
- Seonaid Nolan (ORCID: https://orcid.org/0000-0001-9473-7190)
Institutions
- University of British Columbia (CA)
- British Columbia Centre on Substance Use (CA)
Publication Details
- Journal
- Drug and Alcohol Review
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1111/dar.70062
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health